VAXX

Vaxxinity Inc. (VAXX) | Rumor.io

Vaxxinity

VAXX

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)-56.9M

Social

What share of all stock conversation is about VAXX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Sep 1

$Vaxx has seen a 10x increase in value in the private market.
The token's name "VaxxOnSolana" suggests a connection to vaccines and the Solana blockchain, potentially attracting investors interested in health and efficient trading.
The developer of $Vaxx has a significant amount of the token's supply, which has not been hidden, potentially indicating a large holding.

Generated by AI

Sentiment

Of the messages about VAXX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100% +18.6
Bearish	—	—	—	0% -18.6

Bullish· May 3

Vaxxinity ($VAXX) has strong room for growth, with potential targets at 0.18 and 0.28.
The stock has shown impressive performance, with a 24.14% increase and a strong continuation signal on the 15m chart.
$VAXX is poised for significant gains, with predictions of a 500% increase and a potential for a double or even a 41% increase.

Bearish· Dec 1

$VAXX is in a downtrend, with key support at $3.30 and potential entries above the trendline break at $3.55.
The stock has experienced significant price drops, including a 13.54% decline in the last 20 minutes and an 11.19% drop in the same period.
The stock's price action may be influenced by the FDA's potential approval of Vaxxinity's Covid vaccine, which could lead to a further decline in the stock's value.

Generated by AI

Topics

Of the messages about VAXX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	100%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Dec 2

Vaxxinity, Inc. ($VAXX) announced positive topline pivotal Phase 3 COVID-19 booster data for UB-612, achieving primary and key secondary immunogenicity endpoints.
The company reported that UB-612 generated neutralizing antibody titers after 28 days when delivered as a heterologous booster in three separate substudies.
Vaxxinity's stock was halted for trading on December 2, 2022, pending the announcement of the positive topline data, and later resumed trading at 8:30 A.M.

Generated by AI

Community

Of the messages about VAXX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	72.73%
Newcomers	—	—	—	27.27%

Regulars· Jan 23

$VAXX made a VWAP crossover, with a 10.7% gain and a float of 49.5M, suggesting a potential retest and a momentum system to follow.
The short float for $VAXX is 2.7%, indicating a high level of short interest and potential for a short squeeze.
$VAXX has been experiencing high volatility, with a price drop of -3.9% and a recent pop of 7.1%, suggesting a need for caution and a stop-loss strategy.

Newcomers· May 3

Some newcomers are watching Vaxxinity ($VAXX) for potential price movements, with one user anticipating a strong continuation signal and another setting off a "magic signal" to buy or sell.
There is concern about the stock's recent trading activity, with one user noting "lots of pm volume" and another warning to "trade with caution" due to a form EFFECT filing.
The company has announced its intent to voluntarily delist its Class A common stock from Nasdaq, with the delisting and deregistration expected to become effective on May 9, 2024.

Generated by AI

Also Discussed

Investors talking about VAXX also mention

#	Name	Attention
1	NerdWallet Inc. Class A Common StockNRDS	0%new
2	BGXX - Bright Green Corporation	——
3	Better Therapeutics, Inc.BTTX	0%new
4	Longeveron Inc. Class A Common StockLGVN	0%0
5	T Stamp Inc. Class A Common StockIDAI	0%new
6	Biofrontera Inc.BFRI	0%0
7	Kidpik Corp.PIK	0%new
8	Immix Biopharma, Inc.IMMX	0.01%+0.01
9	MGAM - Mobile Global Esports Inc.	——
10	Brilliant Earth Group, Inc. Class A Common StockBRLT	0%new

Vaxxinity Inc.

Healthcare
Biotechnology

Vaxxinity Inc. is a biotechnology company focusing on developing next-generation vaccines for chronic and infectious diseases. The primary aim of the company is to democratize health by creating vaccines that are accessible, effective, and grounded in innovative science. Vaxxinity's proprietary platform leverages synthetic peptides to train the immune system, an approach that holds promise for both preventive and therapeutic applications. The company's research and development efforts target key health challenges such as Alzheimer’s disease, Parkinson’s, and hypercholesterolemia, among others. Operating at the forefront of the biotechnology sector, Vaxxinity Inc. plays a significant role in advancing medical science and public health. By addressing unmet clinical needs through its unique vaccine platform, Vaxxinity is contributing to the broad landscape of healthcare solutions, impacting both individual health outcomes and public health policies. The company's innovations are part of a broader trend in the biotechnology industry, where cutting-edge research is rapidly transforming potential therapies into tangible health benefits for populations worldwide.

Website

Location

505 Odyssey Way

Merritt Island, FL, 32953

United States

Social

What share of all stock conversation is about VAXX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Sep 1

$Vaxx has seen a 10x increase in value in the private market.
The token's name "VaxxOnSolana" suggests a connection to vaccines and the Solana blockchain, potentially attracting investors interested in health and efficient trading.
The developer of $Vaxx has a significant amount of the token's supply, which has not been hidden, potentially indicating a large holding.

Generated by AI

Sentiment

Of the messages about VAXX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100% +18.6
Bearish	—	—	—	0% -18.6

Bullish· May 3

Vaxxinity ($VAXX) has strong room for growth, with potential targets at 0.18 and 0.28.
The stock has shown impressive performance, with a 24.14% increase and a strong continuation signal on the 15m chart.
$VAXX is poised for significant gains, with predictions of a 500% increase and a potential for a double or even a 41% increase.

Bearish· Dec 1

$VAXX is in a downtrend, with key support at $3.30 and potential entries above the trendline break at $3.55.
The stock has experienced significant price drops, including a 13.54% decline in the last 20 minutes and an 11.19% drop in the same period.
The stock's price action may be influenced by the FDA's potential approval of Vaxxinity's Covid vaccine, which could lead to a further decline in the stock's value.

Generated by AI

Topics

Of the messages about VAXX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	100%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Dec 2

Vaxxinity, Inc. ($VAXX) announced positive topline pivotal Phase 3 COVID-19 booster data for UB-612, achieving primary and key secondary immunogenicity endpoints.
The company reported that UB-612 generated neutralizing antibody titers after 28 days when delivered as a heterologous booster in three separate substudies.
Vaxxinity's stock was halted for trading on December 2, 2022, pending the announcement of the positive topline data, and later resumed trading at 8:30 A.M.

Generated by AI

Community

Of the messages about VAXX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	72.73%
Newcomers	—	—	—	27.27%

Regulars· Jan 23

$VAXX made a VWAP crossover, with a 10.7% gain and a float of 49.5M, suggesting a potential retest and a momentum system to follow.
The short float for $VAXX is 2.7%, indicating a high level of short interest and potential for a short squeeze.
$VAXX has been experiencing high volatility, with a price drop of -3.9% and a recent pop of 7.1%, suggesting a need for caution and a stop-loss strategy.

Newcomers· May 3

Some newcomers are watching Vaxxinity ($VAXX) for potential price movements, with one user anticipating a strong continuation signal and another setting off a "magic signal" to buy or sell.
There is concern about the stock's recent trading activity, with one user noting "lots of pm volume" and another warning to "trade with caution" due to a form EFFECT filing.
The company has announced its intent to voluntarily delist its Class A common stock from Nasdaq, with the delisting and deregistration expected to become effective on May 9, 2024.

Generated by AI

Vaxxinity

Social

Sep 1

Sentiment

Bullish· May 3

Bearish· Dec 1

Topics

Dec 2

Community

Regulars· Jan 23

Newcomers· May 3

Also Discussed

Vaxxinity Inc.

Company Information

Location

Also Discussed

Social

Sep 1

Sentiment

Bullish· May 3

Bearish· Dec 1

Topics

Dec 2

Community

Regulars· Jan 23

Newcomers· May 3